Egalet Priced, Nasdaq: EGLT
Developing abuse-deterrent oral products for the treatment of pain.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
EGLT
Developing abuse-deterrent oral products for the treatment of pain.
| IPO Data | |
|---|---|
| IPO File Date | 10/16/2013 |
| Offer Price | $12.00 |
| Price Range $11.00 - $13.00 | |
| Offer Shares (mm) | 4.2 |
| Deal Size ($mm) | $50 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/05/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $50 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Malvern, PA, United States |
| Founded | 2010 |
| Employees at IPO | 18 |
| Website www.egalet.com | |
IPO News for Egalet
Egalet (EGLT) Performance
